NCT01009879View on ClinicalTrials.gov

Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants

PHASE4WithdrawnINTERVENTIONAL

0

Timeline

Start Date

November 30, 2009

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Etanercept

Etanercept 50 mg SQ qweek

Trial Locations (1)

15261

University of Pittsburgh - Oakland Falk Clinic, Pittsburgh

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Amgen

INDUSTRY

lead

University of Pittsburgh

OTHER